StockViz
RANKINGS
iSpecimen Inc.
NasdaqCM:ISPC
Sector
Industries
Location
Market Cap
USD 2.68 M
Share Price
USD 1.07
Avg Daily Volume
62,760
Change (1 day)
4.37%
Change (1 year)
-82.55%
Change (YTD)
-59.59%
iSpecimen Inc. Income Statement 2019 - 2025
This table shows the Income Statement for iSpecimen Inc. going from 2019 until 2025. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement
| Annual data in millions of USD, except per share data | Trend |
|---|
Competitors
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Novo Nordisk A/S
USD 64.39
NOVO-B.CO
-1.34
-2.03%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
Novartis AG
USD 115.07
NOVN.SW
-0.81
-0.70%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Abbott Laboratories
USD 123.67
ABT
+3.16
2.62%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Amgen Inc.
USD 294.76
AMGN
-3.49
-1.17%
Pfizer Inc.
USD 24.47
PFE
-0.11
-0.45%
Gilead Sciences, Inc.
USD 108.22
GILD
-0.58
-0.53%
Vertex Pharmaceuticals Incorporated
USD 459.81
VRTX
-3.46
-0.75%
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
Bristol-Myers Squibb Company
USD 47.36
BMY
-0.70
-1.46%
CSL Limited
USD 167.39
CSL.AX
+6.23
3.87%
Chugai Pharmaceutical Co., Ltd.
USD 47.05
4519.T
+0.49
1.05%
GSK plc
USD 18.07
GSK.L
-0.88
-4.65%
Zoetis Inc.
USD 148.60
ZTS
-1.43
-0.95%
Regeneron Pharmaceuticals, Inc.
USD 542.52
REGN
-7.48
-1.36%
MERCK Kommanditgesellschaft auf Aktien
USD 128.57
MRK.DE
-0.77
-0.59%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.18
600276.SS
+0.14
1.80%